Australia-based JGA Saddler has filed a class action lawsuit against Johnson & Johnson NZ over its phenylephrine-based cold ...
A lawyer leading a class action lawsuit says New Zealanders may have spent a significant amount on ineffective medicines.
Phenylephrine is a commonly used ingredient in cold and flu medications as a nasal and sinus decongestant. It is present in several on-the-shelf cold and flu medications in New Zealand, including ...
A class action has been filed claiming a pharmaceutical giant sold and marketed in New Zealand cold medicines that did not ...
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...
The FDA reveals that phenylephrine, a popular decongestant, is no better than a placebo. Discover what this means for your ...
ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.
Discover why oral phenylephrine in cold medicine is ineffective for relieving congestion. Learn which alternative treatments ...